2012
DOI: 10.5489/cuaj.83
|View full text |Cite
|
Sign up to set email alerts
|

Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancer

Abstract: Intravesical bacille Calmette-Guérin (BCG) therapy is the most effective treatmentfor high-risk superficial bladder cancer. Severe systemic complications are rare, but may occur in approximately 1% of cases. We report a severe complicationof intravesical BCG: a disseminated Mycobacterium bovis infectionwith biopsy-proven granulomatous hepatitis in a patient with bladder cancer. We also elaborate on the different management alternatives.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0
1

Year Published

2013
2013
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 16 publications
0
12
0
1
Order By: Relevance
“…Disseminated infection ("BCG-itis") following intravesical BCG instillation is a rare, though well-recognized, sideeffect of this treatment modality that may present with an early or late onset [3][4][5][6][7][8][9] . In particular, biopsy-proven, BCGinduced granulomatous hepatitis and pneumonitis may occur in up to 0.7% and 0.2% of cases, respectively [3,4] .…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Disseminated infection ("BCG-itis") following intravesical BCG instillation is a rare, though well-recognized, sideeffect of this treatment modality that may present with an early or late onset [3][4][5][6][7][8][9] . In particular, biopsy-proven, BCGinduced granulomatous hepatitis and pneumonitis may occur in up to 0.7% and 0.2% of cases, respectively [3,4] .…”
Section: Discussionmentioning
confidence: 99%
“…Liver biopsies have been reported with positive acid-fast staining in less than 10% of liver tuberculosis cases [6] . This should not inhibit physicians from instigating the recommended anti-mycobacterial regimen (a combination of isoniazid, rifampicin and ethambutol; M.bovis strains are usually resistant to pyrazinamide) for three to six months combined with steroids for three months, as this therapeutic scheme has been reported to be effective in most of the cases of suspected M.bovis disseminated infection [3,5,7,8] . Thus, although in this case we could not isolate M.bovis from any of the different biological specimens (blood, urine, sputum, bone marrow and liver), we strongly considered the possibility of a BCG-induced disseminated infection, in agreement with observations by other colleagues [5,10] .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Among these, there were 2 deaths [42][43][44][45]. [36][37][38][39] All 6 patients met the criteria for systemic inflammatory immune response during the course of their illness. Common features include fever, hepatosplenomegaly, transaminitis, and elevated inflammatory markers.…”
Section: Hepatic Complicationsmentioning
confidence: 99%